https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high-dose cyclophosphamide and peripheral stem cell support: an Australian and New Zealand Children's Hematology and Oncology Group Study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15288 Sat 24 Mar 2018 08:21:53 AEDT ]]> CAR T cell therapies for diffuse midline glioma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52367 Mon 13 Nov 2023 08:52:16 AEDT ]]>